The global clopidogrel bisulfate market is anticipated to grow at a significant CAGR during the forecast period. Clopidogrel bisulfate is used for the treatment of serious or life-threatening problems with the heart and blood vessels. It is given to people who have had a stroke, heart attack, or severe chest pain. The major factor for the growth of the market during the forecast period is the increasing demand for the medication due to the prevalence of the heart-related disease.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/clopidogrel-bisulfate-market
According to the American Heart Association, in 2018, coronary heart disease was the major cause of mortality that accounted for 365,744 mortalities approximately 13% of mortalities in the US. Additionally, as per the same source, an American will have a heart attack approximately in every 39 seconds. Furthermore, stroke accounted for about 1 of every 19 deaths in the US in 2018. Hence, the rising prevalence of heart diseases is driving the growth of the global clopidogrel bisulfate.
Some major key players in the market include Sanofi S.A., Bristol-Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in August 2017, Sanofi-aventis and Bristol-Myers Squibb Co. announced that their PLAVIX (clopidogrel bisulfate) has been approved by the FDA for the treatment of patients with most severe type of heart attack.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered-
o By Type
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape- Sanofi S.A., Bristol-Myers Squibb Co., and Sun Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Clopidogrel Bisulfate Market Report by Segment
By Type
- 75 mg Tablets
- 300 mg Tablets
By End-User
- Hospitals
- Drug Stores
- Others
A full report of Clopidogrel Bisulfate Market is available at: https://www.omrglobal.com/industry-reports/clopidogrel-bisulfate-market
Clopidogrel Bisulfate Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Sanofi S.A.
- Bristol-Myers Squibb Co.
- Sun Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
